Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) LONDON, ONTARIO - TheNewswire - July 5, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH) , a leading clinical-stage regenerative medicine therapeutics company, held its annual shareholder meeting (the “Meeting”) via the virtua...
(TheNewswire) 25-Year Industry Veteran in Clinical/Regulatory Therapeutics Development Joins Sernova’s Executive Team L ondon, Ontario - TheNewswire - June 30, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH ), a leadi...
(TheNewswire) First Patient Successfully Completes Clinical Trial and Shares Study Experiences and Impact LONDON, ONTARIO - TheNewswire - June 28, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a leading ...
(TheNewswire) Multiple patients with sustained clinical benefit, including positive fasting serum C-peptide (a biomarker of insulin produced by Sernova’s Cell Pouch islets) detected in their bloodstream LONDON, ONTARIO – TheNewswire - June...
(TheNewswire) L ondon, Ontario - TheNewswire - June 1, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF ) (FSE/XETRA:PSH ), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that lead principal investigator Dr. Piot...
(TheNewswire) LONDON, ON – TheNewswire - May 17, 2021 -- Sernova Corp . (TSXV:SVA)(FSE/XETRA:PSH)(OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, today announced that Dr. Philip Toleikis...
(TheNewswire) LONDON, ONTARIO – TheNewswire - May 4, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH ), a leading clinical-stage regenerative medicine therapeutics company, today announced that seasoned pharmaceutical industry executive, Dr. ...
(TheNewswire) LONDON, ONTARIO – TheNewswire - April 28, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH ), a leading clinical-stage regenerative medicine therapeutics company, announced today the highlights of its first virtual Key Opinion Le...
(TheNewswire) LONDON, ONTARIO – TheNewswire - April 21, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH ), a leading clinical-stage regenerative medicine therapeutics company, today announced that it will host a virtual Key Op...
(TheNewswire) Sernova Expands Scientific Advisory Board Expertise for its Innovative Cell Therapy Therapeutic Applications in Endocrine Disorders Including Thyroid Disease LONDON, ONTARIO – TheNewswire - April 14, 2021 – Se...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...